NHP Stock Overview
Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Lumiera Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.025 |
| 52 Week Low | CA$0.005 |
| Beta | 1.95 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -66.67% |
| 3 Year Change | -93.75% |
| 5 Year Change | n/a |
| Change since IPO | -97.92% |
Recent News & Updates
Shareholder Returns
| NHP | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -9.9% | -3.0% |
| 1Y | -66.7% | 46.0% | 3.2% |
Return vs Industry: NHP underperformed the Canadian Pharmaceuticals industry which returned -32.9% over the past year.
Return vs Market: NHP underperformed the Canadian Market which returned -0.8% over the past year.
Price Volatility
| NHP volatility | |
|---|---|
| NHP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 14.1% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: NHP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NHP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.lumiera.ca |
Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. It sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. The company offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand.
Lumiera Health Inc. Fundamentals Summary
| NHP fundamental statistics | |
|---|---|
| Market cap | CA$849.83k |
| Earnings (TTM) | -CA$1.78m |
| Revenue (TTM) | CA$625.94k |
1.4x
P/S Ratio-0.5x
P/E RatioIs NHP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHP income statement (TTM) | |
|---|---|
| Revenue | CA$625.94k |
| Cost of Revenue | CA$329.16k |
| Gross Profit | CA$296.78k |
| Other Expenses | CA$2.08m |
| Earnings | -CA$1.78m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.01 |
| Gross Margin | 47.41% |
| Net Profit Margin | -284.17% |
| Debt/Equity Ratio | -268.3% |
How did NHP perform over the long term?
See historical performance and comparison